JPRN-UMIN000023043已完成未知
Clinical study on the safety and efficacy of medium-chain fatty acid capsules (CNT-02) for primary triglyceride deposit cardiomyovasculopathy (TGCV) and neutral lipid storage disease with myopathy (NLSD-M) - Clinical study on the safety of CNT-02 for TGCV and NLSD-M
Translational Research Informatics Center, Foundation for Biomedical Research and Innovation0 个研究点目标入组 10 人开始时间: 2016年8月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with diabetic ketoacidosis. 2) Patients with the possibility of diabetic ketoacidosis (patients with poorly controlled diabetes mellitus [HbA1c>8.4%, NGSP]) 3) Patients with terminal malignancy. 4) Pregnant or lactating women. 5) Patients who do not consent to using contraception while participating in this study. 6) Patients allergic to MCT oil. 7) Patients participating in other clinical trial. 8) Otherwise, patients determined to be ineligible for this study by the investigator or sub-investigator.
研究者
相似试验
已完成
不适用
A study to check the hydration benefitsCTRI/2023/02/049513HNL Business Services India Private Limited36
招募中
1 期
Clinical study on the new orthodontic anchor screwObstacle of the supporting tissue of other teeth and the toothMalocclusionJPRN-jRCTs032180394Moriyama Keiji10
已完成
Unknown
A clinical study on the efficacy and safety of the scent of essential oils for depressiodepressive stateJPRN-UMIN000051570Okinawa Prefecture10
进行中（未招募）
不适用
Clinical study of the safety and effectiveness of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) as fillers in the treatment of lip thinness and wrinkles around the mouthISRCTN30768206Sinclair Pharma68
已完成
不适用
Clinical study of the safety and effectiveness of the use of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) in the treatment of facial skin depressions of the mid-faceFor MaiLi Precise® treatment: mild to moderate nasolabial folds and/or subjects with mild to moderate tear trough. For MaiLi Define® treatment: moderate to severe nasolabial folds and/or moderate to severe marionette lines.Skin and Connective Tissue DiseasesISRCTN10761529Sinclair Pharma68